311 related articles for article (PubMed ID: 27889809)
21. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
[TBL] [Abstract][Full Text] [Related]
23. Low-energy diets differing in fibre, red meat and coffee intake equally improve insulin sensitivity in type 2 diabetes: a randomised feasibility trial.
Nowotny B; Zahiragic L; Bierwagen A; Kabisch S; Groener JB; Nowotny PJ; Fleitmann AK; Herder C; Pacini G; Erlund I; Landberg R; Haering HU; Pfeiffer AF; Nawroth PP; Roden M
Diabetologia; 2015 Feb; 58(2):255-64. PubMed ID: 25425219
[TBL] [Abstract][Full Text] [Related]
24. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover study.
Kahleova H; Belinova L; Malinska H; Oliyarnyk O; Trnovska J; Skop V; Kazdova L; Dezortova M; Hajek M; Tura A; Hill M; Pelikanova T
Diabetologia; 2014 Aug; 57(8):1552-60. PubMed ID: 24838678
[TBL] [Abstract][Full Text] [Related]
25. U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study.
Diabetes; 1985 Aug; 34(8):793-8. PubMed ID: 2862087
[TBL] [Abstract][Full Text] [Related]
26. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
[TBL] [Abstract][Full Text] [Related]
27. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial.
Tay J; Luscombe-Marsh ND; Thompson CH; Noakes M; Buckley JD; Wittert GA; Yancy WS; Brinkworth GD
Diabetes Care; 2014 Nov; 37(11):2909-18. PubMed ID: 25071075
[TBL] [Abstract][Full Text] [Related]
28. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
[TBL] [Abstract][Full Text] [Related]
29. Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus.
Gougeon R
Obes Res; 2001 Apr; 9(4):241-50. PubMed ID: 11331427
[TBL] [Abstract][Full Text] [Related]
30. A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin.
Berne C;
Diabet Med; 2005 May; 22(5):612-8. PubMed ID: 15842517
[TBL] [Abstract][Full Text] [Related]
31. Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.
Shi YF; Pan CY; Hill J; Gao Y
Diabet Med; 2005 Dec; 22(12):1737-43. PubMed ID: 16401321
[TBL] [Abstract][Full Text] [Related]
32. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.
Yki-Järvinen H; Kauppinen-Mäkelin R; Tiikkainen M; Vähätalo M; Virtamo H; Nikkilä K; Tulokas T; Hulme S; Hardy K; McNulty S; Hänninen J; Levänen H; Lahdenperä S; Lehtonen R; Ryysy L
Diabetologia; 2006 Mar; 49(3):442-51. PubMed ID: 16456680
[TBL] [Abstract][Full Text] [Related]
33. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.
Lim EL; Hollingsworth KG; Aribisala BS; Chen MJ; Mathers JC; Taylor R
Diabetologia; 2011 Oct; 54(10):2506-14. PubMed ID: 21656330
[TBL] [Abstract][Full Text] [Related]
34. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.
Ludvik B; Giorgino F; Jódar E; Frias JP; Fernández Landó L; Brown K; Bray R; Rodríguez Á
Lancet; 2021 Aug; 398(10300):583-598. PubMed ID: 34370970
[TBL] [Abstract][Full Text] [Related]
35. Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.
Shao N; Kuang HY; Hao M; Gao XY; Lin WJ; Zou W
Diabetes Metab Res Rev; 2014 Sep; 30(6):521-9. PubMed ID: 24823873
[TBL] [Abstract][Full Text] [Related]
36. A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes.
Nwosu BU; Maranda L; Cullen K; Greenman L; Fleshman J; McShea N; Barton BA; Lee MM
PLoS One; 2015; 10(9):e0137525. PubMed ID: 26367281
[TBL] [Abstract][Full Text] [Related]
37. Withdrawal of medications leads to worsening of OGTT parameters in youth with impaired glucose tolerance or recently-diagnosed type 2 diabetes.
Hannon TS; Edelstein SL; Arslanian SA; Caprio S; Zeitler PS; Buchanan TA; Ehrmann DA; Mather KJ; Tripputi M; Kahn SE; Nadeau KJ;
Pediatr Diabetes; 2020 Dec; 21(8):1437-1446. PubMed ID: 32985775
[TBL] [Abstract][Full Text] [Related]
38. The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control.
Heilbronn LK; Noakes M; Clifton PM
J Am Coll Nutr; 2002 Apr; 21(2):120-7. PubMed ID: 11999539
[TBL] [Abstract][Full Text] [Related]
39. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Rosenstock J; Rood J; Cobitz A; Biswas N; Chou H; Garber A
Diabetes Obes Metab; 2006 Nov; 8(6):650-60. PubMed ID: 17026489
[TBL] [Abstract][Full Text] [Related]
40. Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction.
Ascić-Buturović B; Kacila M
Bosn J Basic Med Sci; 2008 Nov; 8(4):309-12. PubMed ID: 19125700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
